Alkem Laboratories Ltd - 539523 - Board to consider Interim Dividend
Alkem Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on February 08, 2019, inter alia :1. To consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2018; and2. To consider and approve Interim Dividend for the Financial Year 2018-2019. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q3FY19 and 9MFY19 financial results will be held on Friday, 8th February, 2019 at 5.00 P.M. Please find attached herewith the conference call details. Kindly take note of the same. Alkem Laboratories Ltd - 539523 - Intimation Of Record Date Pursuant To Regulation 42 Of The Securities & Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
The record date for the purpose of payment of interim dividend for the Financial Year 2018-2019, would be Monday, 18th February, 2019, subject to declaration of the said interim dividend by the Board of Directors in its meeting to be held on 8th February, 2019 Alkem Laboratories Ltd - 539523 - Board Meeting Intimation for Notice Of Meeting Of Board Of Directors Of Alkem Laboratories Limited ('The Company')
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2019 ,inter alia, to consider and approve Notice is hereby given to the Stock Exchanges under Regulation 29 read with Regulation 33 and Regulation 42 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ('Listing Regulations') that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, 8th February, 2019, inter alia (i) to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended 31st December, 2018; and (ii) to consider and approve Interim Dividend for the Financial Year 2018-2019. The record date for the purpose of payment of interim dividend for the Financial Year 2018-2019, would be Monday, 18th February, 2019, subject to declaration of the said interim dividend by the Board of Directors in its meeting to be held on 8th February, 2019. USFDA nod may boost Alkem Laboratories
Alkem Laboratories on Friday said it has not received any observations from the United States Food and Drug Administration for its Daman facility. The Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
This is to inform you that US FDA had conducted an inspection at the Company's manufacturing facility located at Daman, India from 14th January, 2019 to 18th January, 2019. At the end of the inspection, no Form 483 was issued. Kindly take note of the same. Alkem Laboratories Ltd - 539523 - Shareholding for the Period Ended December 31, 2018
Alkem Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here Alkem Laboratories Ltd - 539523 - Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Manish NarangDesignation :- Company Secretary and Compliance Officer Alkem Laboratories Ltd - 539523 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Alkem Laboratories Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Alkem Laboratories Ltd - 539523 - Voting Results Of The Postal Ballot Process And Remote E-Voting - Regulation 44(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
In continuation of our letter dated 6th December, 2018 and pursuant to provisions of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the resolutions as proposed in the Postal Ballot Notice dated 2nd November, 2018 have been passed by the members of the Company with requisite majority. We are enclosing herewith the details regarding the voting results of the business transacted through Postal Ballot process (including Remote E-voting) in the prescribed format alongwith the Scrutinizer's Report. The same are also being uploaded on Company's website. The approval is deemed to have been received on the last date of receipt of postal ballot forms, i.e. on 5th January, 2019. Kindly take the same on record.